{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Survey Questionnaire

(To be filled only by physician)


A multi-centric, cross-sectional and observational survey study to understand the role of Olopatadine 0.7% eye drops for the treatment of ocular itching associated with allergic conjunctivitis
  1. How often do you encounter conjunctivitis cases in your practice?*

  2. Which type of conjunctivitis do you most frequently encounter? *

  3. What is your preferred method of diagnosing conjunctivitis? *

  4. How do you differentiate allergic conjunctivitis from other types? *

  5. Do you perform any specific tests to identify the causative allergen in allergic conjunctivitis cases? *

  6. Which age group is most commonly affected by allergic conjunctivitis in your experience? *

  7. Do you recommend any lifestyle modifications to manage allergic conjunctivitis? *

  8. Which antiallergic medications do you commonly prescribe for allergic conjunctivitis? *

  9. How do you determine the appropriate duration of topical antiallergic treatment for conjunctivitis? *

  10. What percentage of your conjunctivitis patients experience relief with topical antiallergic medications alone? *

  11. Have you encountered any cases of conjunctivitis with resistance to topical antiallergic medications? *

  12. Do you use combination therapy for severe allergic conjunctivitis cases? *

  13. How do you manage recurrent or chronic allergic conjunctivitis cases? *

  14. What percentage of your conjunctivitis patients are prescribed systemic antiallergic medications? *

  15. How do you monitor the efficacy of antiallergic treatment for conjunctivitis? *

  16. In your experience, what is the average time for symptom resolution with antiallergic treatment? *

  17. Do you educate patients about allergen avoidance strategies for allergic conjunctivitis? *

  18. What is your preferred topical antiallergic medication for pediatric conjunctivitis patients? *

  19. What do you prefer to manage conjunctivitis cases in pregnant or lactating patients? *

  20. What do you prefer to manage conjunctivitis in patients with pre-existing ocular conditions (e.g., dry eye, glaucoma)? *

  21. How frequently do you prescribe olopatadine for conjunctivitis management? *

  22. At what stage of conjunctivitis do you typically initiate olopatadine treatment? *

  23. What is the most common dosage form of olopatadine that you prescribe for allergic conjunctivitis? *

  24. Which of the following strengths of olopatadine that you commonly prefer for allergic conjunctivitis? *

  25. How frequently do you advise patients to use olopatadine eye drops per day? *

  26. What is the usual duration of olopatadine treatment for conjunctivitis? *

  27. Do you recommend olopatadine eye drops for both acute and chronic conjunctivitis cases? *

  28. Which of the following ocular symptoms do you consider most responsive to olopatadine treatment? *

  29. Do you recommend olopatadine eye drops as a monotherapy or combination therapy for conjunctivitis? *

  30. How do you educate patients about the proper use of antiallergic eye drops? *